GOMEL REGIONAL CLINICAL
ONCOLOGICAL DISPENSARY

The Department of Thoracic Surgery specializes in the diagnosis and surgical treatment of tumors of the lung, chest, esophagus, diaphragm and stomach.

Branch staff

Konnov Dmitry Yurievich
Konnov Dmitry YurievichHead of the Department
Doctor-oncologist of the highest qualification category. Graduated from the Gomel State Medical Institute in 1997.
Tishkevich Oleg Gennadievich.
Tishkevich Oleg Gennadievich.Doctor-oncologist of the highest category
He graduated from the Gomel State Medical Institute in 1997.
Tihmanovich Evgeniy Evgenevich
Tihmanovich Evgeniy EvgenevichHead. Endoscopic department the highest category oncologist
Graduated from the Gomel State Medical Institute in 1993
Bereznyatsky Alexander Vladimirovich.
Bereznyatsky Alexander Vladimirovich.Doctor-oncologist of the highest category
He graduated from the Minsk State Medical University in 2000.
Ponomarev Denis Mikhailovich
Ponomarev Denis MikhailovichDoctor-oncologist of the highest category
He graduated from the Gomel State Medical Institute in 1999.
Voronov Oleg Viktorovich
Voronov Oleg ViktorovichOncologist of the 1st category
Graduated from Gomel State Medical University in 2009
Pohozhaj Vladimir Vladimirovich
Pohozhaj Vladimir VladimirovichAssistant of the Department of Oncology of the State Medical University
Graduated from Gomel State Medical University in 2011
Poladieva Natalia Viktorovna
Poladieva Natalia ViktorovnaSenior Nurse

The employees of our department have a full range of thoracic operations, including the entire volume of operations on the lungs, esophagus, stomach and minimally invasive thoracoscopic surgery.

Employees of the department work as a team to obtain the best result of treatment. Thoracic surgeons work in close contact with doctors of related specialties, colleagues from other medical institutions of the city and the republic. Experienced, highly qualified middle and technical staff helps doctors.

Employees of the department work as a team to obtain the best result of treatment. Thoracic surgeons work in close contact with doctors of related specialties, colleagues from other medical institutions of the city and the republic. Experienced, highly qualified middle and technical staff helps doctors.

In most cases, the tactics of treating the patient is determined within two to three days. During hospitalization, patients receive medical assistance according to protocols and the standard of treatment for cancer patients in the Republic of Belarus (order MZ RB No. 258). The length of hospitalization depends on the amount of surgical intervention, the course of the postoperative period, the concomitant pathology and the need for further special treatment.

The staff of the department strive to make the patients' stay as comfortable as possible during the entire period of hospitalization and contributes to a speedy recovery.

This email address is being protected from spambots. You need JavaScript enabled to view it.
+375 (232) 49-18-61
+375 (232) 49-17-16
Post of the nurse: +375 (232) 49-19-24

Head of the Department: 
Konnov Dmitry Yurievich
+375 (44) 7447969


Estimated cost of surgical treatment for foreign citizens in the oncological thoracic department.

Item No.

the name of the operation

Duration

Treatment,

Days

Estimated cost, USD

1

Gastrectomy, subtotal proximal gastrectomy

eleven

950 - 1200

2

Operations on the lungs open (lobectomy, pulmonectomy)

eleven

830 - 960

3

Diagnostic videomedioscopy, videotorakoscopy

6th

350 - 400

4

Videotoracoscopic removal of tumors of the lung, mediastinum, pleura,

6th

630 - 830

5

Subtotal resection

(Extirpation of the esophagus)

12

1500 - 1630


Useful links:

 

The algorithm for examining risk groups The algorithm for examining risk groups

The project of the algorithm of the population survey of the Gomel region for the purpose of early diagnosis of lung cancer

At the first stage, it is necessary to form a risk group for developing lung cancer, which shows an in-depth examination.

Criteria for inclusion in risk groups are:

Persons aged 50-70 years for men, 40-60 for women, and having at least one of the following characteristics:

  • Experience of smoking more than 15 years more than 15 cigarettes a day;
  • The presence of chronic recurrent lung diseases in the anamnesis;
  • Work in harmful production for more than 10 years;
  • A history of tuberculosis;
  • The presence of an anamnesis of lung cancer in close relatives.

The next stage after the allocation of risk groups proposed the following survey algorithm:

1. The annual mandatory radiographic or fluorographic examination according to the plans for general medical examination.

2. In the absence of clinical manifestations on the part of the organs of the broncho-pulmonary system, the absence of changes in the planned X-ray examination - fibrobronchoscopy and multislice computed tomography of the thorax organs in the planned order every 2 years.

3. In the absence of clinical manifestations and the presence of changes in the lungs during a planned X-ray examination - fibrobronchoscopy and multislice computed tomography of the chest organs, depending on the conclusion of the radiologist (ie, in the near future with suspicion of cancer, or in routine order).

4. In the presence of recurrent complaints from the side of the broncho-pulmonary system and the absence of changes in the radiographic examination - multislice computed tomography of the thorax organs in a planned manner.

5. In the presence of complaints from the bronchopulmonary system and changes in the X-ray examination - fibrobronchoscopy and multislice computed tomography of chest organs in terms of pre-examination are mandatory.

6. In the presence of clinical and roentgenological signs of cancer, light fibrobronchoscopy and multislice computed tomography of chest organs in the near future.

 

About Smoking About Smoking

SMOKING AND LUNG CANCER - RELATED TO ONE CHAIN?

140 more years ago, lung cancer was a rarity, and the men who were ill with them, and only men, were demonstrated at major medical conferences. But by the middle of the twentieth century, lung cancer among British subjects in terms of morbidity overtook tuberculosis and became "purely English" and exclusively a male disease. As risk factors for lung cancer, researchers considered all sorts of reasons, but not smoking tobacco. In 1948, British scientists Richard Doll and Bradford Hill conducted the first epidemiological study. The conclusions shocked: lung cancer develops only in smokers, while 80% of British men smoke and only 0.5% of the population has never tasted tobacco. And the risk of developing a tumor is proportional to the number of cigarettes smoked: for those smoking more than 25 cigarettes a day, the risk of getting sick was 50 times higher. Dr. Doll, Shocked by the results, he himself quit smoking and others recommended, but his cancer still "caught up": the scientist died of a lung tumor at 92 years old, confirming the results of his own study. In 2004, who continued to work actively, Sir Richard Doll published the results of a 50-year observation of almost 35,000 British smokers. The study proved that smoking men are twice as likely to die before they reach the age of 70. The refusal of a bad habit at the age of 60 lengthened life by 3 years, the refusal of 50 years added 6 years of life, at the age of 40 added 9 years, well, and with unconditional refusal to smoke not later than the 30th anniversary, one could hope for 10 additional years of life . Why do not all smokers suffer from cancer? Since the middle of the last century, doctors have been convinced that lung cancer is provided only to malicious smokers. Those who lived to a very advanced age, smokers were considered a mistake of nature, somehow strayed from the deadly path beaten by tobacco. In the present century, Russians confirmed the practice of the conclusions of British scientists: the transition in the late 80's from the vigorous Soviet tobacco to foreign producers responded to a decrease in the incidence of lung cancer, but rather, the time to the development of a malignant tumor simply increased. American researchers did not begin to wonder why they did not get sick, but studied the genomes of the 90th anniversary of 90 elderly smokers and 6447 non-smoking long-livers. Discovered a network of 215 polymorphic genes that allow smoking and not contracting lung cancer, promising to meet the 90th anniversary and step over the centenary. Of course, it is not 100% to get all these pleasant preferences, but with some probability, For example, the probability of not getting cancer at 11%, and living more than 90 years - 22%. Unusual combinations of genes, apparently, affect the resistance of the body to diseases and negative factors of the environment. Many of these genes were known earlier, they were called "longevity genes". Unique genes have slowed the aging of experimental animals that live longer than their relatives. True, it remains to be seen what biochemical reactions are controlled by these gene networks, and how the protective effect is realized. Lung cancer in women who never smoked Women at the end of the twentieth century, women rarely suffered from lung cancer, as a rule, an unpleasant exception to the rule was made by never-smelling Asian women. Clinical failure with an innovative antitumor drug, Which turned out to be completely useless in one group of patients, while in the other the convincing result was demonstrated, made the scientists "penetrate" into the genomes of lung tumors. There were three genetic variants associated with an increased risk of lung cancer in non-smokers. The lung cancer suffered from cancer of two segments of the sixth chromosome and one section of the tenth chromosome, but there was no change in the site of the fifteenth chromosome characteristic of the "male" cancer of the smoker. Women with altered chromosomes were Asian blood and never smoked, and the drug did not exert any positive influence on their tumors. This study developed cancer chemotherapy to actively study the genetic and other features of malignant tumors, And today before the prescription of the medicine it is necessary to clearly represent the genotype of each tumor so that the treatment does not become vain. The appearance of a person is determined by its genotype, but variants are possible, and none of the Russians are able to vouch that there were no Asians in his ancestors. Cancer Records According to the latest forecasts of Italian and Swiss researchers, in 2015 for the first time the death rate from lung cancer in Europe will exceed the death rate from breast cancer. Since 2009, the mortality rate of European women against lung cancer has increased by 9%, while in breast cancer it decreased by 10.2%. During the last five-year period in 28 countries of the European Union, the mortality from malignant tumors has been steadily declining: the male has fallen by 7.5% and the female by 6%. The worst indicator for Britons, Where 21 out of 100,000 women die from lung cancer, and Poles - 17, Spaniards get sick less often, and only 8 out of a hundred thousand die, but this is also not considered a good indicator. Why did it happen so? Scientists suggest that all is to blame for smoking. During the Second World War, British women began to smoke to forget the horrors of bombing. Most Europeans started smoking after 1968, then it became fashionable. Englishwomen are leading in the incidence of lung cancer, because young people have added to the cohort of survivors of the war and who have lit from grief. The peak of cancer mortality was recorded in Europe in 1988, since then the development of cancer science has reduced the mortality rate of men by 26%, women - by 21%. Do not "keep up" with the statistics are only lung and pancreatic cancer in women, and morbidity and mortality are increasing.

Source: http://www.euroonco.ru/patcientam/profilaktika-raka/kurenie-rak-lyogkogo

PATIENTS WITH CANCER OF LUNGS THAT MOVED TO SMOKE, LIVE LONGER

July 15, 2015 at 15:25 Lung cancer patients who quit smoking shortly before or after diagnosis, live longer, regardless of the severity of the disease. Such data were obtained during a study conducted at the Roswell Park Cancer Institute (Roswell Park Cancer Institute), the results are published in the Journal of Thoracic Oncology (Journal of Thoracic Oncology). The Roswell Park Cancer Institute uses a unique program that actively identifies all smokers who are admitted to the thoracic center for treatment, provide counseling services to get rid of bad habits. Using data obtained during the implementation of the program, the researchers conducted a study in which 250 patients took part. Among those, Who recently quit smoking alone (50 patients) or after consultations (71 patients), the survival rate was higher than among those who continued to smoke. The median survival rate among patients who reported that they quit smoking was 28 months, compared to 18 months among those who could not or did not want to give up tobacco. After that, the scientists again analyzed the indicators, taking into account the demography, stage of the disease and the health status of the participants in the study. Mary Reid, head of the study: "According to our data, this is the first study of the effect of cessation of tobacco use on life expectancy among patients with lung cancer." Scientists also suggested that survival rates increase in patients who could not completely abandon tobacco, but are making attempts to quit smoking. Mortality among those who "broke" and returned to a bad habit, was the same as among those who continued to smoke. Information on the use of tobacco by patients is rarely collected in such a standardized, prospective way that in future it can be used to conduct clinical research and evaluate outcomes, according to Dr. Reed. Taking into account the effect of smoking cessation on survival in lung cancer, methods of controlling tobacco use and help services in getting rid of bad habits should be introduced into the standards of clinical practice, the researchers say. This will improve the survival and quality of life of patients. Source: sciencedaily.com Information on the use of tobacco by patients is rarely collected in such a standardized, prospective way that in future it can be used to conduct clinical research and evaluate outcomes, according to Dr. Reed. Taking into account the effect of smoking cessation on survival in lung cancer, methods of controlling tobacco use and help services in getting rid of bad habits should be introduced into the standards of clinical practice, the researchers say. This will improve the survival and quality of life of patients. Source: sciencedaily.com Information on the use of tobacco by patients is rarely collected in such a standardized, prospective way that in future it can be used to conduct clinical research and evaluate outcomes, according to Dr. Reed. Taking into account the effect of smoking cessation on survival in lung cancer, methods of monitoring tobacco use and help services in getting rid of bad habits should be introduced into the standards of clinical practice, the researchers say. This will improve the survival and quality of life of patients. Source: sciencedaily.com Methods to control the use of tobacco and helpdesk in getting rid of bad habits should be introduced into the standards of clinical practice, the researchers say. This will improve the survival and quality of life of patients. Source: sciencedaily.com Methods to control the use of tobacco and helpdesk in getting rid of bad habits should be introduced into the standards of clinical practice, the researchers say. This will improve the survival and quality of life of patients. Source: sciencedaily.com

Source: http://www.euroonco.ru/science-news/bolnye-rakom-legkih-kotorye-brosili-kurit

 

 

Stomach cancer Stomach cancer
 

Stomach cancer

Gastric cancer is a disease in which malignant (cancerous) cells form in the mucous membrane of the stomach.

Causes

The risk of developing gastric cancer increases with the presence of infection - the bacterium Helicobacter pylori in the stomach. This study can be done by passing a gastroscopy with a biopsy (a slice of the mucosa). Strict diet, alcohol abuse and peptic ulcer disease can affect the risk of developing stomach cancer.

Risk factors for developing gastric cancer include the following:

  • The presence of any of the following diseases:
  • Helicobacter pylori (H.)
  • Infections of the stomach.
  • Chronic gastritis (inflammation of the stomach).
  • Anemia.
  • Intestinal metaplasia.
  • Peptic ulcer or polyps of the stomach.
  • Family history - cases of stomach cancer in close relatives.
  • Nutrition is the abuse of foods high in salt, smoked foods, low in fruits and vegetables.
  • Abuse of alcohol.
  • Smoking cigarettes.

Symptoms

Often, stomach cancer develops asymptomatically and its presence can be suspected only in the analysis of cancer markers and the presence of prolonged difficult-to-treat anemia. When the tumor begins to squeeze nearby tissues and nerves, pain and the following symptoms begin to appear:

  • Pain at the top of the abdomen.
  • Loss of appetite.
  • Weight loss for an unknown reason.
  • Nausea, discomfort after eating.
  • Frequent vomiting, heartburn.
  • Prolonged constipation or diarrhea, bloating.
  • Weakness.
  • Possible signs of stomach cancer include indigestion and discomfort or pain.

In later stages of stomach cancer, the following problems may occur:

  • Blood in the stool.
  • Jaundice (yellowing of the skin, mucous membrane and eyes).
  • Ascites (accumulation of fluid in the abdominal cavity).
  • Problems with swallowing.

Metastases

Cancer of the stomach gives metastases primarily to the liver, lungs, kidneys, brain, lymph nodes.

Diagnostics

The basic diagnostic program includes:

  • Studying an anamnesis, a family history of the patient
  • Various blood tests (biochemistry, general, hemoglobin, cancer markers CA72.4, CEA and CA19.9)
  • Ultrasound of internal organs and lymph nodes.
  • Endoscopic examination of the gastric mucosa with biopsy
  • Pathological examination of the biopsy specimen for the analysis of the structure of cells. Biopsy is the only reliable way to detect cancer cells.

If doctors are suspected of having a cancer, in particular gastric cancer, additional tests can be prescribed.

  • Fecal occult blood test
  • Computed Tomography (CT)
  • MRI
  • Chest X-ray
  • Endoscopic ultrasound (EUS) or endosonography
  • Laparoscopy
  • PET (positron emission tomography)

Treatment

Treatment of stomach cancer, mainly surgical. At subsequent stages, chemotherapy and radiation can be used. Treatment for stomach cancer may include the following:

  • An operation to remove a cancerous tumor and some healthy tissue around it.
  • Operation to remove residual tumor after radiation therapy and / or chemotherapy.

In the case of metastatic stomach cancer, in addition to surgery, the question of the order of chemotherapy and / or irradiation therapy

In later stages, stomach cancer can be treated, but rarely can be cured.

Relapse of stomach cancer

After treatment of the main tumor, a recurrence of cancer can happen elsewhere - lymph nodes, liver or intestines. For control, the patient receives precise instructions for further examination and its regularity.

Forecast

The prognosis for stomach cancer (chances of recovery) depends on how much the cancer has spread at the time of diagnosis.

 

Lungs' cancer Lungs' cancer

Lungs' cancer

Lung cancer begins when abnormal cells begin to grow in the lung tissue. Lung cancer and smoking often, but not always, go hand in hand.

He usually has no signs or early symptoms, and those that are - like a smoker's cough or pneumonia, and can include coughing, wheezing, shortness of breath and in advanced stages - bloody mucus.

Causes

Causes of lung cancer are smoking - both active and passive, inflammatory chronic lung diseases, as well as the influence of carcinogens.

• With regard to smoking statistics gives a clear answer - the longer the experience of the smoker and the worse the quality of cigarettes, the higher the risk of developing lung cancer.

• Chronic diseases increase the likelihood of developing lung cancer, the most dangerous are tuberculosis, bronchiectasis, COPD and pneumosclerosis.

• Work or prolonged exposure to carcinogens increases the risk of developing lung cancer; these are: arsenic, chromium, nickel and asbestos-related industries (especially asbestos dust), heavy metals and chloromethyl ether.

Symptoms

The fourth part of all people with lung cancer have no symptoms at the time of diagnosis of lung cancer. These tumors are usually determined by chest X-ray, which is carried out for another reason. The remaining three quarters of the population turn to the doctor if they have anxious signs: prolonged cough, hemoptysis or rusty sputum, increased fatigue, unexplained weight loss, chronic respiratory infections, hoarseness, snoring and shortness of breath, chest pains - dull, aching, Prolonged, shortness of breath.

It is important to note that these symptoms may indicate the development of several respiratory diseases and, if there are two or more worrisome symptoms, contact your doctor for the necessary diagnosis (see below)

Diagnostics

Lung cancer is divided into two main types - small cell and non-small cell. This classification is based on the microscopic structure of tumor cells. Their difference is expressed not only in the structure of cells, but also in the symptomatology and spread of cancer.

Small cell lung cancer is the most aggressive and fast-growing form of lung cancer, inextricably linked with smoking - about 99% of detected small-cell cancers in smokers. In addition to rapid growth and metastasis, it has an unfavorable prognosis, as it is found most often at an advanced stage and is difficult to treat.

Non-small cell lung cancer is the most common lung cancer, accounting for about 80% of all cases, it has three main types, which are called cell-based types in the tumor. These include: adenocarcinomas, squamous cell carcinoma, undifferentiated lung cancer.

• Types of lung cancer - more ...

Types of lung cancer diagnosis:

• Chest X-ray is shown as the first examination in the presence of anxiety symptoms

• CT of the chest can be ordered for a more detailed examination.

• Mucus analysis - sputum cytology for lung cancer

• Biopsy by bronchoscopy

• Needle biopsy of lung fluid (the so-called pleurocentesis) through a puncture of the thorax under the supervision of ultrasound

• Thoracocentesis of lung cancer - Thorascopic biopsy - taking fluid and tissue under the control of a mini-video camera

• Mediastinoscopy - analysis of nearby lymph nodes for the presence of cancer cells

• PET CT - Positron Emission Tomography

• Scintigraphy - scanning of bones

• MRI or CT of the brain - lung cancer with blood flow metastasizes to the brain

Metastases

Lung cancer spreads with a current of lymph and blood and metastasizes primarily to the liver, bones (spine, ribs and thighs) and the brain, which creates an absolutely unfavorable prognosis and difficulties in treatment.

Other primary tumors of different locations often metastasize with blood or lymph flow to the lungs, and therefore CT of the chest or PET CT is the gold standard in the diagnosis of many cancers. The peculiarity of metastatic lung cancer is that the foci are multiple and are concentrated in the outer regions of the lungs, and not in the central part, as in lung cancer.

Treatment

In the treatment of lung cancer of various types, there are six standard approaches, namely: surgery, chemotherapy, radiation therapy, photodynamic therapy, ablation and a cyber knife.

• Operation: various resections depending on the location of the tumor and its size, lobectomy (removal of the lobe of the lung), pulmonectomy (removal of the whole lung). Only surgery is the standard effective method of treating lung cancer.

• Radiation cancer therapy is a treatment that uses high-energy X-rays or other types of radiation to kill cancer cells.

• Radiosurgery or gamma knife, a cyber-knife, is a method of delivering radiation directly to the tumor, thus killing the tumor at a distance, but not instantaneously, but gradually.

• A variety of radiation therapy - Stereotactic Radiation Therapy of the body (SBRT). In SBRT high doses of radiation therapy are focused and irradiate the tumor directly from different points.

• Chemotherapy. The method of chemotherapy depends on the type and stage of the cancer.

• Laser therapy to treat cancer uses a laser beam (narrow beam of intense light) to kill cancer cells. Laser therapy is usually used as a palliative care to remove a tumor that blocks the airways. Laser therapy does not cure lung cancer.

• Photodynamic therapy (PDT) uses medicines (Photofrin), and certain types of laser light to kill cancer cells. The drug is injected into a vein and accumulated in cancer cells, it is activated by a certain type of rays, thus light kills cancer cells. It is intended for palliative treatment, does not treat cancer.

• Radiofrequency ablation is an operation performed under the supervision of ultrasound - the doctor inserts a special needle directly into the tumor, warming up its tissues to 42-45 degrees, thus killing the tumor and overlapping the small capillaries, reducing bleeding.

• Cryoablation - cryosurgery of lung cancer is an experimental method of treatment and is currently used only in some clinical trials.

• Prophylactic head irradiation (PCI) to prevent metastasis of non-small cell lung cancer.

• Pleurocenosis, thoracocentesis is used to remove fluid from around the lungs (pleurisy).

• Oxygen therapy - Oxygen therapy can reduce shortness of breath.

Prognosis of lung cancer

In the case of untreated lung cancer, 87% of the patients die within 2 years of the diagnosis. Using the surgical method, you can achieve a 30% survival rate for patients over 5 years. Early detection of the tumor allows to increase the chances of cure: at the stage of T1N0M0 it reaches 80%. Joint surgical, radiotherapy and medical treatment

Allows you to raise the 5-year survival rate by another 40%. The presence of metastases significantly worsens the prognosis.

 

Esophageal carcinoma Esophageal carcinoma

Tumors of the esophagus

Tumors of the esophagus can be benign (not cancer) and malignant (cancer). Esophagus cancer is a disease in which malignant cells form in the tissues in the esophagus and with possible spread to the upper part of the stomach. A tumor can develop in both adults and children, each age group has its own risk factors and its treatment regimens.

Diagnosis of tumors of the esophagus

As diagnostic tests, invasive and non-invasive methods can be used:

Non-invasive diagnostic tests for esophageal tumors

• Inspection and collection of medical history by the therapist.

• Chest X-ray.

• Ultrasound scanning.

• CT or MRI of the chest with special contrast.

• PET CT is used at an advanced stage of the disease, when there is a fear that the cancer has gone beyond the boundaries of the tumor.

• Invasive tests

• Esophagoscopy. With it, you can perform a biopsy site and identify precancerous changes in the mucosa.

• Bronchoscopy. A bronchoscope is inserted through the nose or mouth into the trachea and lungs, it can be used to examine the trachea for the presence of tumors, and also perform a biopsy.

• Thoracoscopy: a surgical procedure for examining the organs inside the chest to check for abnormal areas identified in the pictures.

• Laparoscopy: a surgical procedure for examining the organs inside the abdominal cavity to detect signs of disease.

Treatment

The main method of treating esophageal cancer or cardioesophageal zone remains the operation, despite the fact that simultaneous chemoradiotherapy gives similar results. Since both of these approaches can lead to a cure, it is very important to start the correct treatment in the skilled hands of surgeons and oncologists.

Forecast

Low rates of five-year survival in the CIS are due to the inability of surgeons to completely remove the tumor of the esophagus and save the patient a quality of life - the possibility of feeding and breathing on their own. Therefore, many patients are refused treatment and transfer to palliative care.

 

Statistics Statistics

Lung cancer

In various countries of the world, the incidence of malignant neoplasms of the trachea, bronchi and lung is at a high level. The main share in the group of these diseases is lung cancer (99.6%). Primary neoplasms of the trachea are rare. The incidence of malignant neoplasms of the lungs across countries has two to threefold differences. In many European countries, morbidity rates range from 20-30 per 100,000 inhabitants. Indicators exceeding these values ​​were recorded in Denmark (39.2), Poland (38.0), Netherlands (37.2). The North American continent has high levels of high incidence rates in both the US (38.4) and Canada (37.9). Belarus is part of a group of countries with an average incidence rate in Europe, which differs little from the Baltic and Russian countries, but 1.5 times lower, Than in neighboring Poland. In most countries of the world, men significantly (3 times or more) are more likely to contract lung tumors than women, but this pattern is not observed in all countries. Exceptions are the Netherlands, Denmark, the United States and Canada, where the prevalence of men is 1.1-1.4 times, and Sweden, where the incidence of sex is practically the same. In Belarus and neighboring countries, the greatest (7-10 times) differences in the incidence of men and women are revealed, and the largest - are observed in our country. From the characteristics of international statistics it is important to note that in all countries the ratio of mortality to morbidity is high, which indicates the existing problems of radical treatment of tumors of this localization. The range of fluctuations of these indicators from 72.3% in France to 89.6% - in Russia. At the same time, Belarus has comparable results with many European countries (71.2%). It is important to note that according to the predicted data of GLOBOCAN 2012, the ratio of these indicators for Belarus was expected to be much higher than for the updated information of the registry register, which is explained by the increased effectiveness of treatment and the expansion of indications for its use over the past 10 years. Currently, in the structure of malignant neoplasms of Belarus lung cancer is 9.1%, among men - 15.9%, and among women - 2.4%. The most common tumors affect the upper and lower lobes (42.6% and 23.1%). Which is explained by the increase in the effectiveness of treatment and the expansion of indications for its use over the past 10 years. Currently, in the structure of malignant neoplasms of Belarus lung cancer is 9.1%, among men - 15.9%, and among women - 2.4%. The most common tumors affect the upper and lower lobes (42.6% and 23.1%). Which is explained by the increase in the effectiveness of treatment and the expansion of indications for its use over the past 10 years. Currently, in the structure of malignant neoplasms of Belarus lung cancer is 9.1%, among men - 15.9%, and among women - 2.4%. The most common tumors affect the upper and lower lobes (42.6% and 23.1%).

Esophageal carcinoma

Among the various countries of the world, the incidence of malignant neoplasms of the esophagus is relatively rare. The incidence rates of countries range from 2.2 - 2.3 in Poland, Estonia and Finland to 6.3 - 6.6 in the Netherlands and the United Kingdom. Belarus is included in the group of countries with a relatively low incidence. In all countries, there are significant differences in the incidence of sex, men are much more likely to be affected by this disease than women (2-3 times more often in Denmark and 11-14 times more often in Ukraine and Belarus). From the features of international statistics it is important to note that in all countries the ratio of mortality to morbidity is very high, which indicates the seriousness of the problem of radical treatment of malignant neoplasms of the esophagus. According to the Belarusian Candidate Register, the indicator was 71, 9% and was close to the level of Switzerland (68.4%), Germany (65.7%) and France (76.3%). In many other countries this ratio exceeds 85% (Estonia - 100%, Denmark - 105.1%). Currently, the incidence rate of all malignant neoplasms in Belarus is 1.2%. Most often affects the middle and lower third of the esophagus (45.5% and 27.3%).

Gomel regional clinical oncological dispensary

© 2012-2017

Продвижение и разработка сайтов в Минске - Аliva.by